Intra Cellular Therapies reported $553.59M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 564.84M 16.77M
Adamas Pharmaceuticals ADMS:US -4033000 9.97M
ALKERMES ALKS:US $ 1097.9M 46.75M
Aptinyx Inc APTX:US $ 130.76M 18.18M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
Biocryst Pharmaceuticals BCRX:US $ -106.08M 31.09M
Biogen BIIB:US $ 10751.9M 69.7M
Bristol Myers Squibb BMY:US $ 36808M 797M
Cytokinetics CYTK:US $ 16.49M 51.36M
Esperion Therapeutics ESPR:US $ -304310000 34.92M
Gilead Sciences GILD:US $ 19710M 758M
Gw Pharmaceuticals GWPH:US $ 736.37M 4.72M
Halozyme Therapeutics HALO:US $ 119.75M 52.15M
Intra Cellular Therapies ITCI:US $ 553.59M 58.56M
JAZZ PHA JAZZ:US $ 4131.49M 333.8M
Marinus Pharmaceuticals MRNS:US $ 95.06M 20.27M
Minerva Neurosciences NERV:US $ 36.17M 9.2M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Novartis NVS:US $ 54042M 3519M
Prothena PRTA:US $ 288.21M 53.62M
Redhill Biopharma RDHL:US $ 29.58M 23.46M
Supernus Pharmaceuticals SUPN:US $ 785.58M 31.14M
United Therapeutics UTHR:US $ 3639.5M 194.1M
Vanda Pharmaceuticals VNDA:US $ 481.22M 13.59M
Zogenix ZGNX:US $ 272.86M 48.42M